Mediso completes acquisition of MRI spectrometer

By staff writers

April 26, 2021 -- Multimodality imaging technology provider Mediso Medical Imaging Systems has purchased the intellectual property of Cameleon4, an MRI spectrometer developed by longtime partner and French spectrometer firm RS2D.

The deal builds on an existing technology license and commercial agreement between Mediso and RS2D over the last seven years for nanoScan, a line of 3-tesla and 7-tesla MRI scanners based on cryogen-free superconducting magnet technology. In 2019, the companies also completed a technology transfer deal for the nanoScan intellectual property.

As a result of the new deal, Cameleon4 has been integrated into the nanoScan product line. Financial terms were not disclosed.

Copyright © 2021

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking